Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.85 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.80 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.80 |
| ▸ | AURKA | O14965 | 2/20 | 0.80 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.80 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL366095 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Dodecanoyl-Coa SCHEMBL4309283 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2934083 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Decanoyl-Coa SCHEMBL24667667 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1129961 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL24667663 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL11027446 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL2370508 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20970006 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Dodecanoyl-Coa SCHEMBL187868 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117980473-A | Organisms producing less crotonic acid | 环球生物能源公司 | 2024-05-03 | — | — | CN | claimed |
| CN-116157518-A | Pichia pastoris mutant strain with improved sphingolipid and sphingoid base productivity and preparation method thereof | 索路思生物技术有限公司 | 2023-05-23 | — | — | CN | claimed |
| CN-119857063-A | Composition, ceramide liposome freeze-dried powder, and preparation method and application thereof | 深圳瑞德林生物技术有限公司 | 2025-04-22 | — | — | CN | disclosed |
| CN-119630646-A | TEAD targeting compounds and methods thereof | 新加坡科技研究局 | 2025-03-14 | — | — | CN | disclosed |
| CN-119541901-A | Drug permeability clinical prediction model, construction method thereof and nonspecific drug permeability evaluation method | 北京大学第一医院(北京大学第一临床医学院) | 2025-02-28 | — | — | CN | disclosed |
| CN-119405642-A | Application of rhodotorula erythrosin in preparation of product for effectively preventing/treating hypercholesteremia | 江南大学 | 2025-02-11 | — | — | CN | disclosed |
| WO-2024197185-A1 | METHODS AND COMPOSITIONS FOR DISSECTING ORGANELLE PHYSIOLOGY | THE BROAD INSTITUTE, INC. (US) | 2024-09-26 | — | — | WO | disclosed |
| CN-118339307-A | Biosynthetic preparation of vitamin A compounds | 康纳根有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-112771169-B | Method for recovering water-immiscible isoprenoid compounds from microbial biomass | 阿迈瑞斯公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-118021974-A | Application of palmitoylation of Cys113 and Cys274 sites of MyD88 protein in treatment of non-alcoholic fatty liver disease | 重庆医科大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-117980473-A | Organisms producing less crotonic acid | 环球生物能源公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2001062744-A2 | SUBSTITUTED PIPERAZINE COMPOUNDS | CV THERAPEUTICS, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2001062711-A2 | SUBSTITUTED ALKYLENE DIAMINE COMPOUNDS | CV THERAPEUTICS, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2001062749-A1 | SUBSTITUTED PIPERAZINE COMPOUNDS | CV THERAPEUTICS, INC. (US) | 2001-08-30 | — | — | WO | disclosed |
| WO-2000070017-A2 | METHODS USING OF FAB I AND COMPOUNDS MODULATING FAB I ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2000-11-23 | — | — | WO | disclosed |
| EP-0932387-A1 | SKIN CARE COMPOSITIONS CONTAINING COMBINATIONS OF COMPOUNDS FOR MIMICKING THE EFFECT ON SKIN OF RETINOIC ACID | UNILEVER PLC (GB) | 1999-08-04 | — | — | EP | disclosed |
| EP-0872244-A1 | Cosmetic or pharmaceutical composition containing an Andiroba extract | LABORATOIRES DE BIOLOGIE VEGETALE YVES ROCHER (FR) | 1998-10-21 | — | — | EP | disclosed |
| US-5759556-A | Skin care compositions containing certain cyclic aliphatic unsaturated compounds and retinol or retinyl ester | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1998-06-02 | — | — | US | disclosed |
| WO-1998013020-A1 | SKIN CARE COMPOSITIONS CONTAINING COMBINATIONS OF COMPOUNDS FOR MIMICKING THE EFFECT ON SKIN OF RETINOIC ACID | UNILEVER PLC (GB) | 1998-04-02 | — | — | WO | disclosed |
| EP-0243167-B1 | A NOVEL MICROORGANISM, A NOVEL ESTERASE AND METHOD FOR PREPARING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-08-19 | — | — | EP | disclosed |